An experimental BTLA agonist that Eli Lilly cut from its pipeline for lupus late last year failed to show strong enough ...
Indivior's shares $INDV have lost nearly a third of their value this week, following the company's announcement Tuesday that ...
The blank-check acquisition companies Launch One Acquisition and SIM Acquisition went public this week, a signal that the ...
Roche’s Spark Ther­a­peu­tics is let­ting staffers go and has “dis­con­tin­ued” sev­er­al ear­ly-stage pro­grams, a ...
The Supreme Court's decision late last month to overrule a decades-old legal doctrine will have major ramifications for the ...
The UK’s cen­ter-left Labour Par­ty won a land­slide vic­to­ry at last week’s gen­er­al elec­tion, end­ing the cen­ter-right ...
While M&A is typ­i­cal­ly a boon to the share­hold­ers of an ac­quired start­up, it can al­so be quite lu­cra­tive for the ...
The chief scientific officer at gene editing company Metagenomi is out, the company confirmed to Endpoints News.
The Senate in a unanimous vote Thursday afternoon passed a bill that aims to tackle pharmaceutical patent abuses by limiting ...
Novartis, in an effort to “evolve” its global development organization, is set to exit a technical research and development ...
Novo Nordisk’s once-weekly insulin has been turned down by the FDA, and the Danish pharma likely won't be refiling until next ...
Pfizer is making a move on its obesity pipeline after multiple quarters of questions from investors and analysts. The New ...